Nanox Reports Q2 Revenue Growth but Faces Wider GAAP Loss Due to $40.7 Million Impairment
Nanox (NASDAQ:NNOX) reported a 37% year-over-year increase in second-quarter revenue, reaching $4.2 million, driven largely by the acquisition of Nanox Health IT, which contributed $0.9 million to quarterly earnings. Despite this growth, the company recorded a significant GAAP net loss of $55.5 million due primarily to a non-cash impairment charge of $40.7 million related to its AI solutions business. The impairment was attributed to declining stock prices and reduced revenue forecasts. The adjusted EBITDA loss also widened to $11.3 million from the prior year, indicating ongoing operational challenges despite rising revenues. Nanox's cash reserves dropped to $31.4 million as of June 30, down sharply from $60.0 million at the end of 2025. The company has since raised an additional $8.5 million through a registered direct offering and AT-the-market program but plans further fundraising efforts. Commercial progress includes initial patient scans in Philadelphia under its Nanox Imaging Network and expanded U.S. distribution partnerships, yet conversion of equipment into active clinical use remains critical for future performance.
Tickers: $NNOX
Topics: cash_position gaap_loss impairment_charge revenue_growth